Literature DB >> 12969565

A general method allowing the design of oligonucleotide primers to amplify the variable regions from immunoglobulin cDNA.

S Essono1, Y Frobert, J Grassi, C Créminon, D Boquet.   

Abstract

The amplification of variable regions of immunoglobulins by reverse transcription polymerase chain reaction (RT-PCR) has become an invaluable technique either for the cloning of monoclonal antibodies (mAbs), or for the building of single-chain fragment variable (ScFv) libraries. Numerous applications have been described either for studying the antigen-antibody interactions or for medical purposes, with the recent development of recombinant antibodies for therapeutic use. Several publications by different groups have reported primer sequences to perform such amplification, but the strategy used to design these primers, and particularly the way of performing the necessary alignments, generally appear poorly detailed. In the present work, we propose a rational method of designing primers in order to amplify the variable region of heavy chain (VH) and variable region of light chain (VL) domains for framework 1 (FR1) of immunoglobulins. The described sets of primers have been designed to hybridize with the entire VH and VL mouse repertory without modification of amino acids since amino acids of framework 1 play a role in the folding, and thus in the functionality, of recombinant antibody. These primers have been applied to the cloning of monoclonal antibodies previously produced in the laboratory. This approach can be extended to other species or members of the immunoglobulin superfamily.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12969565     DOI: 10.1016/s0022-1759(03)00242-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  6 in total

1.  Hybridization-based antibody cDNA recovery for the production of recombinant antibodies identified by repertoire sequencing.

Authors:  Javier Valdés-Alemán; Juan Téllez-Sosa; Marbella Ovilla-Muñoz; Elizabeth Godoy-Lozano; Daniel Velázquez-Ramírez; Humberto Valdovinos-Torres; Rosa E Gómez-Barreto; Jesús Martinez-Barnetche
Journal:  MAbs       Date:  2013-12-11       Impact factor: 5.857

2.  Plant-based expression of a partially humanized neutralizing monoclonal IgG directed against an immunodominant epitope on the ricin toxin A subunit.

Authors:  Joanne M O'Hara; Kevin Whaley; Michael Pauly; Larry Zeitlin; Nicholas J Mantis
Journal:  Vaccine       Date:  2011-12-22       Impact factor: 3.641

3.  Targeting the C-terminus of galectin-9 induces mesothelioma apoptosis and M2 macrophage depletion.

Authors:  Pietro Bertino; Thomas A Premeaux; Tsuyoshi Fujita; Brien K Haun; Michael P Marciel; Fukun W Hoffmann; Alan Garcia; Haining Yiang; Sandra Pastorino; Michele Carbone; Toshiro Niki; John Berestecky; Peter R Hoffmann; Lishomwa C Ndhlovu
Journal:  Oncoimmunology       Date:  2019-04-17       Impact factor: 8.110

4.  Degenerated primer design to amplify the heavy chain variable region from immunoglobulin cDNA.

Authors:  Ying Wang; Wei Chen; Xu Li; Bing Cheng
Journal:  BMC Bioinformatics       Date:  2006-12-12       Impact factor: 3.169

5.  Rapid discovery and optimization of therapeutic antibodies against emerging infectious diseases.

Authors:  J Rogers; R J Schoepp; O Schröder; T L Clements; T F Holland; J Q Li; J Li; L M Lewis; R P Dirmeier; G J Frey; X Tan; K Wong; G Woodnutt; M Keller; D S Reed; B E Kimmel; E C Tozer
Journal:  Protein Eng Des Sel       Date:  2008-05-13       Impact factor: 1.650

6.  Molecular characterization of monoclonal antibodies that inhibit acetylcholinesterase by targeting the peripheral site and backdoor region.

Authors:  Yves Bourne; Ludovic Renault; Sosthène Essono; Grégoire Mondielli; Patricia Lamourette; Didier Boquet; Jacques Grassi; Pascale Marchot
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.